\contentsline {chapter}{Preface}{12}{chapter*.2}%
\contentsline {section}{Usage}{12}{section*.3}%
\contentsline {section}{Curriculum Calendar}{12}{section*.4}%
\contentsline {section}{Additional Resources}{13}{section*.5}%
\contentsline {section}{Comments, Questions or Contributions}{13}{section*.6}%
\contentsline {chapter}{Authors and Contributors}{14}{chapter*.7}%
\contentsline {part}{\numberline {I}Head and Neck}{17}{part.1}%
\contentsline {chapter}{\numberline {1}Cerebrovascular}{18}{chapter.1}%
\contentsline {section}{\numberline {1.1}Available Guidelines}{18}{section.1.1}%
\contentsline {section}{\numberline {1.2}Presentation}{18}{section.1.2}%
\contentsline {section}{\numberline {1.3}Evaluation}{19}{section.1.3}%
\contentsline {section}{\numberline {1.4}Management}{20}{section.1.4}%
\contentsline {subsection}{\numberline {1.4.1}Medical - Asymptomatic Patients}{20}{subsection.1.4.1}%
\contentsline {subsection}{\numberline {1.4.2}Medical - Symptomatic Patients}{21}{subsection.1.4.2}%
\contentsline {subsection}{\numberline {1.4.3}Surgical - Carotid Endarterectomy}{22}{subsection.1.4.3}%
\contentsline {subsubsection}{\numberline {1.4.3.1}Indications}{22}{subsubsection.1.4.3.1}%
\contentsline {subsubsection}{\numberline {1.4.3.2}Techniques}{23}{subsubsection.1.4.3.2}%
\contentsline {subsubsection}{\numberline {1.4.3.3}Complications}{25}{subsubsection.1.4.3.3}%
\contentsline {subsubsection}{\numberline {1.4.3.4}Outcomes and Surveillence}{26}{subsubsection.1.4.3.4}%
\contentsline {subsection}{\numberline {1.4.4}Endovascular - Carotid Artery Stenting}{27}{subsection.1.4.4}%
\contentsline {subsubsection}{\numberline {1.4.4.1}Indications}{27}{subsubsection.1.4.4.1}%
\contentsline {subsubsection}{\numberline {1.4.4.2}Technique}{27}{subsubsection.1.4.4.2}%
\contentsline {subsubsection}{\numberline {1.4.4.3}Outcomes and Surveillance}{28}{subsubsection.1.4.4.3}%
\contentsline {subsection}{\numberline {1.4.5}Summary of Prospective Trials}{28}{subsection.1.4.5}%
\contentsline {section}{\numberline {1.5}Uncommon Carotid Disease}{30}{section.1.5}%
\contentsline {subsection}{\numberline {1.5.1}Complicated Extracranial Occlusive Disease}{30}{subsection.1.5.1}%
\contentsline {subsection}{\numberline {1.5.2}Vertebrobasilar Disease}{31}{subsection.1.5.2}%
\contentsline {subsection}{\numberline {1.5.3}Carotid artery dissection}{32}{subsection.1.5.3}%
\contentsline {subsection}{\numberline {1.5.4}Internal Carotid Artery Aneurysms}{32}{subsection.1.5.4}%
\contentsline {subsection}{\numberline {1.5.5}Carotid Body Tumors (CBT)}{32}{subsection.1.5.5}%
\contentsline {subsubsection}{\numberline {1.5.5.1}Demographics}{32}{subsubsection.1.5.5.1}%
\contentsline {subsubsection}{\numberline {1.5.5.2}Management}{33}{subsubsection.1.5.5.2}%
\contentsline {chapter}{\numberline {2}Trauma - Cerebrovascular}{34}{chapter.2}%
\contentsline {section}{\numberline {2.1}Neck Exposure Techniques}{34}{section.2.1}%
\contentsline {subsection}{\numberline {2.1.1}Carotid Artery}{34}{subsection.2.1.1}%
\contentsline {subsection}{\numberline {2.1.2}Vertebral Artery}{36}{subsection.2.1.2}%
\contentsline {section}{\numberline {2.2}Tenets of Cerebrovascular Injury}{38}{section.2.2}%
\contentsline {section}{\numberline {2.3}Blunt Trauma}{38}{section.2.3}%
\contentsline {subsection}{\numberline {2.3.1}Evaluation}{38}{subsection.2.3.1}%
\contentsline {subsection}{\numberline {2.3.2}Management}{39}{subsection.2.3.2}%
\contentsline {section}{\numberline {2.4}Penetrating Trauma}{41}{section.2.4}%
\contentsline {subsection}{\numberline {2.4.1}Management}{41}{subsection.2.4.1}%
\contentsline {section}{\numberline {2.5}Internal Jugular Vein Injuries}{44}{section.2.5}%
\contentsline {part}{\numberline {II}Upper Extremity}{45}{part.2}%
\contentsline {chapter}{\numberline {3}Upper Extremity}{46}{chapter.3}%
\contentsline {section}{\numberline {3.1}Overview}{46}{section.3.1}%
\contentsline {subsection}{\numberline {3.1.1}Anatomy}{46}{subsection.3.1.1}%
\contentsline {subsection}{\numberline {3.1.2}Etiology}{49}{subsection.3.1.2}%
\contentsline {subsection}{\numberline {3.1.3}Evaluation}{49}{subsection.3.1.3}%
\contentsline {section}{\numberline {3.2}Vaso-occlusive Disease}{50}{section.3.2}%
\contentsline {subsection}{\numberline {3.2.1}Demographics}{50}{subsection.3.2.1}%
\contentsline {subsection}{\numberline {3.2.2}Management}{51}{subsection.3.2.2}%
\contentsline {subsubsection}{\numberline {3.2.2.1}Chronic Limb Threatening Ischemia}{51}{subsubsection.3.2.2.1}%
\contentsline {subsubsection}{\numberline {3.2.2.2}Acute Limb Ischemia}{53}{subsubsection.3.2.2.2}%
\contentsline {section}{\numberline {3.3}Vasospastic Disorders}{54}{section.3.3}%
\contentsline {subsection}{\numberline {3.3.1}Iatrogenic or Vasopressor Induced Ischemia}{54}{subsection.3.3.1}%
\contentsline {subsection}{\numberline {3.3.2}Raynaud's Phenomenon}{54}{subsection.3.3.2}%
\contentsline {subsection}{\numberline {3.3.3}Ergotism}{55}{subsection.3.3.3}%
\contentsline {subsection}{\numberline {3.3.4}Buerger's Disease}{56}{subsection.3.3.4}%
\contentsline {subsection}{\numberline {3.3.5}Large Artery Vasculitis}{57}{subsection.3.3.5}%
\contentsline {subsubsection}{\numberline {3.3.5.1}Takayasu arteritis}{58}{subsubsection.3.3.5.1}%
\contentsline {subsubsection}{\numberline {3.3.5.2}Giant cell arteritis}{58}{subsubsection.3.3.5.2}%
\contentsline {subsubsection}{\numberline {3.3.5.3}Management}{59}{subsubsection.3.3.5.3}%
\contentsline {subsubsection}{\numberline {3.3.5.4}Surveillance}{59}{subsubsection.3.3.5.4}%
\contentsline {subsection}{\numberline {3.3.6}Other Vasculitis syndromes}{60}{subsection.3.3.6}%
\contentsline {section}{\numberline {3.4}Aneurysmal Disease}{60}{section.3.4}%
\contentsline {subsection}{\numberline {3.4.1}Subclavian Artery Aneurysms}{60}{subsection.3.4.1}%
\contentsline {subsection}{\numberline {3.4.2}Axillary Artery Aneurysms}{61}{subsection.3.4.2}%
\contentsline {subsection}{\numberline {3.4.3}Brachial Artery Aneurysms}{62}{subsection.3.4.3}%
\contentsline {subsection}{\numberline {3.4.4}Radial Artery Pseudoaneurysm}{63}{subsection.3.4.4}%
\contentsline {section}{\numberline {3.5}Occupational Vascular Disease}{63}{section.3.5}%
\contentsline {subsection}{\numberline {3.5.1}Hand-Arm Vibration Syndrome}{63}{subsection.3.5.1}%
\contentsline {subsection}{\numberline {3.5.2}Hypothenar hammer syndrome}{64}{subsection.3.5.2}%
\contentsline {subsection}{\numberline {3.5.3}Environmental Exposures}{65}{subsection.3.5.3}%
\contentsline {section}{\numberline {3.6}Sports Medicine}{66}{section.3.6}%
\contentsline {subsection}{\numberline {3.6.1}Quadrilateral space syndrome}{66}{subsection.3.6.1}%
\contentsline {subsection}{\numberline {3.6.2}Humeral head compression of axillary artery}{67}{subsection.3.6.2}%
\contentsline {subsection}{\numberline {3.6.3}Thoracic Outlet Syndrome}{67}{subsection.3.6.3}%
\contentsline {section}{\numberline {3.7}Vascular Trauma-Upper Extremity}{67}{section.3.7}%
\contentsline {subsection}{\numberline {3.7.1}Subclavian Artery Trauma}{68}{subsection.3.7.1}%
\contentsline {subsection}{\numberline {3.7.2}Axillary Artery Trauma}{68}{subsection.3.7.2}%
\contentsline {subsection}{\numberline {3.7.3}Brachial Artery Trauma}{69}{subsection.3.7.3}%
\contentsline {subsection}{\numberline {3.7.4}Radial/ulnar artery trauma}{69}{subsection.3.7.4}%
\contentsline {section}{\numberline {3.8}Upper Extremity Lymphedema}{70}{section.3.8}%
\contentsline {subsection}{\numberline {3.8.1}Etiology}{70}{subsection.3.8.1}%
\contentsline {subsection}{\numberline {3.8.2}Management}{70}{subsection.3.8.2}%
\contentsline {chapter}{\numberline {4}Thoracic Outlet}{71}{chapter.4}%
\contentsline {section}{\numberline {4.1}Overview}{71}{section.4.1}%
\contentsline {subsection}{\numberline {4.1.1}Demographics}{71}{subsection.4.1.1}%
\contentsline {subsubsection}{\numberline {4.1.1.1}Anatomy}{71}{subsubsection.4.1.1.1}%
\contentsline {subsubsection}{\numberline {4.1.1.2}Etiology}{73}{subsubsection.4.1.1.2}%
\contentsline {subsubsection}{\numberline {4.1.1.3}Presentation}{74}{subsubsection.4.1.1.3}%
\contentsline {subsection}{\numberline {4.1.2}Evaluation}{74}{subsection.4.1.2}%
\contentsline {subsubsection}{\numberline {4.1.2.1}Clinical Examination}{74}{subsubsection.4.1.2.1}%
\contentsline {subsubsection}{\numberline {4.1.2.2}Imaging}{75}{subsubsection.4.1.2.2}%
\contentsline {subsection}{\numberline {4.1.3}Management}{76}{subsection.4.1.3}%
\contentsline {subsubsection}{\numberline {4.1.3.1}Complications}{77}{subsubsection.4.1.3.1}%
\contentsline {section}{\numberline {4.2}Venous (vTOS)}{77}{section.4.2}%
\contentsline {subsection}{\numberline {4.2.1}Demographics}{77}{subsection.4.2.1}%
\contentsline {subsubsection}{\numberline {4.2.1.1}Presentation}{78}{subsubsection.4.2.1.1}%
\contentsline {subsection}{\numberline {4.2.2}Evaluation}{78}{subsection.4.2.2}%
\contentsline {subsection}{\numberline {4.2.3}Management}{79}{subsection.4.2.3}%
\contentsline {subsubsection}{\numberline {4.2.3.1}Medical Management}{79}{subsubsection.4.2.3.1}%
\contentsline {subsubsection}{\numberline {4.2.3.2}Surgery}{79}{subsubsection.4.2.3.2}%
\contentsline {subsection}{\numberline {4.2.4}Summary}{80}{subsection.4.2.4}%
\contentsline {subsubsection}{\numberline {4.2.4.1}Controversy}{80}{subsubsection.4.2.4.1}%
\contentsline {subsubsection}{\numberline {4.2.4.2}Landmark papers}{80}{subsubsection.4.2.4.2}%
\contentsline {section}{\numberline {4.3}Arterial (aTOS)}{81}{section.4.3}%
\contentsline {subsection}{\numberline {4.3.1}Presentation}{81}{subsection.4.3.1}%
\contentsline {subsection}{\numberline {4.3.2}Evaluation}{82}{subsection.4.3.2}%
\contentsline {subsection}{\numberline {4.3.3}Management}{82}{subsection.4.3.3}%
\contentsline {section}{\numberline {4.4}Neurogenic (nTOS)}{83}{section.4.4}%
\contentsline {subsection}{\numberline {4.4.1}Demographics}{83}{subsection.4.4.1}%
\contentsline {subsubsection}{\numberline {4.4.1.1}Presentation}{83}{subsubsection.4.4.1.1}%
\contentsline {subsection}{\numberline {4.4.2}Management}{84}{subsection.4.4.2}%
\contentsline {chapter}{\numberline {5}Hemodialysis}{85}{chapter.5}%
\contentsline {section}{\numberline {5.1}Planning access creation}{85}{section.5.1}%
\contentsline {section}{\numberline {5.2}Techniques for access creation}{90}{section.5.2}%
\contentsline {subsection}{\numberline {5.2.1}Anesthetic Considerations}{91}{subsection.5.2.1}%
\contentsline {subsection}{\numberline {5.2.2}Endovascular AV Fistula}{92}{subsection.5.2.2}%
\contentsline {section}{\numberline {5.3}Maintenance and complications}{92}{section.5.3}%
\contentsline {subsection}{\numberline {5.3.1}Failure to mature}{92}{subsection.5.3.1}%
\contentsline {subsection}{\numberline {5.3.2}Access Failure}{93}{subsection.5.3.2}%
\contentsline {subsection}{\numberline {5.3.3}Steal Syndrome}{95}{subsection.5.3.3}%
\contentsline {subsection}{\numberline {5.3.4}Neuropathy and Neuropraxia}{97}{subsection.5.3.4}%
\contentsline {subsection}{\numberline {5.3.5}Perioperative neuropraxia}{97}{subsection.5.3.5}%
\contentsline {subsection}{\numberline {5.3.6}Bleeding and Aneurysm}{98}{subsection.5.3.6}%
\contentsline {section}{\numberline {5.4}Dialysis Catheters}{98}{section.5.4}%
\contentsline {section}{\numberline {5.5}Peritoneal Dialysis}{99}{section.5.5}%
\contentsline {part}{\numberline {III}Thorax}{100}{part.3}%
\contentsline {chapter}{\numberline {6}Aortic Dissection}{101}{chapter.6}%
\contentsline {section}{\numberline {6.1}Demographics}{101}{section.6.1}%
\contentsline {subsection}{\numberline {6.1.1}Classification and Terminology}{102}{subsection.6.1.1}%
\contentsline {subsubsection}{\numberline {6.1.1.1}Penetrating Aortic Ulcer and Intramural Hematoma}{103}{subsubsection.6.1.1.1}%
\contentsline {subsection}{\numberline {6.1.2}Presentation}{105}{subsection.6.1.2}%
\contentsline {section}{\numberline {6.2}Evaluation}{106}{section.6.2}%
\contentsline {section}{\numberline {6.3}Management}{106}{section.6.3}%
\contentsline {chapter}{\numberline {7}TAAA}{109}{chapter.7}%
\contentsline {section}{\numberline {7.1}Demographics}{109}{section.7.1}%
\contentsline {subsection}{\numberline {7.1.1}Anatomy}{109}{subsection.7.1.1}%
\contentsline {subsection}{\numberline {7.1.2}Etiology}{111}{subsection.7.1.2}%
\contentsline {section}{\numberline {7.2}Management}{113}{section.7.2}%
\contentsline {subsection}{\numberline {7.2.1}Ascending aorta and arch}{113}{subsection.7.2.1}%
\contentsline {subsection}{\numberline {7.2.2}Isolated Thoracic Aneurysms}{114}{subsection.7.2.2}%
\contentsline {subsection}{\numberline {7.2.3}Thoracoabdominal Aneurysms}{115}{subsection.7.2.3}%
\contentsline {subsubsection}{\numberline {7.2.3.1}Complications}{119}{subsubsection.7.2.3.1}%
\contentsline {chapter}{\numberline {8}Aortopathies}{128}{chapter.8}%
\contentsline {section}{\numberline {8.1}General Considerations}{128}{section.8.1}%
\contentsline {section}{\numberline {8.2}Demographics}{129}{section.8.2}%
\contentsline {section}{\numberline {8.3}Evaluation}{130}{section.8.3}%
\contentsline {section}{\numberline {8.4}Management}{131}{section.8.4}%
\contentsline {subsection}{\numberline {8.4.1}Medical Management}{131}{subsection.8.4.1}%
\contentsline {subsection}{\numberline {8.4.2}Surgery}{131}{subsection.8.4.2}%
\contentsline {section}{\numberline {8.5}Summary}{133}{section.8.5}%
\contentsline {section}{\numberline {8.6}Additional Resources}{133}{section.8.6}%
\contentsline {chapter}{\numberline {9}Trauma - Endo}{134}{chapter.9}%
\contentsline {section}{\numberline {9.1}Blunt Thoracic Aortic Injury (BTAI)}{134}{section.9.1}%
\contentsline {subsection}{\numberline {9.1.1}Demographics}{134}{subsection.9.1.1}%
\contentsline {subsubsection}{\numberline {9.1.1.1}Guidelines}{134}{subsubsection.9.1.1.1}%
\contentsline {subsubsection}{\numberline {9.1.1.2}Epidemiology}{135}{subsubsection.9.1.1.2}%
\contentsline {subsubsection}{\numberline {9.1.1.3}Anatomy}{136}{subsubsection.9.1.1.3}%
\contentsline {subsubsection}{\numberline {9.1.1.4}Grading Systems}{136}{subsubsection.9.1.1.4}%
\contentsline {subsection}{\numberline {9.1.2}Evaluation}{137}{subsection.9.1.2}%
\contentsline {subsection}{\numberline {9.1.3}Management}{138}{subsection.9.1.3}%
\contentsline {section}{\numberline {9.2}Blunt Abdominal Aortic Injuries}{141}{section.9.2}%
\contentsline {subsection}{\numberline {9.2.1}Demographics}{141}{subsection.9.2.1}%
\contentsline {subsubsection}{\numberline {9.2.1.1}Epidemiology}{141}{subsubsection.9.2.1.1}%
\contentsline {subsubsection}{\numberline {9.2.1.2}Anatomy}{141}{subsubsection.9.2.1.2}%
\contentsline {subsection}{\numberline {9.2.2}Evaluation}{141}{subsection.9.2.2}%
\contentsline {subsection}{\numberline {9.2.3}Management}{142}{subsection.9.2.3}%
\contentsline {section}{\numberline {9.3}Blunt Axillo-Subclavian Injuries}{142}{section.9.3}%
\contentsline {subsection}{\numberline {9.3.1}Demographics}{142}{subsection.9.3.1}%
\contentsline {subsection}{\numberline {9.3.2}Management}{143}{subsection.9.3.2}%
\contentsline {part}{\numberline {IV}Abdomen}{145}{part.4}%
\contentsline {chapter}{\numberline {10}AAA}{146}{chapter.10}%
\contentsline {section}{\numberline {10.1}Demographics}{146}{section.10.1}%
\contentsline {subsection}{\numberline {10.1.1}Etiology}{147}{subsection.10.1.1}%
\contentsline {section}{\numberline {10.2}Evaluation}{150}{section.10.2}%
\contentsline {subsection}{\numberline {10.2.1}Imaging}{151}{subsection.10.2.1}%
\contentsline {section}{\numberline {10.3}Management}{152}{section.10.3}%
\contentsline {subsection}{\numberline {10.3.1}EVAR}{157}{subsection.10.3.1}%
\contentsline {subsubsection}{\numberline {10.3.1.1}Endoleak}{159}{subsubsection.10.3.1.1}%
\contentsline {subsection}{\numberline {10.3.2}Open Repair}{161}{subsection.10.3.2}%
\contentsline {subsubsection}{\numberline {10.3.2.1}Complications}{164}{subsubsection.10.3.2.1}%
\contentsline {subsubsection}{\numberline {10.3.2.2}Postoperative Surveillance}{166}{subsubsection.10.3.2.2}%
\contentsline {subsection}{\numberline {10.3.3}Ruptured Aneurysms}{167}{subsection.10.3.3}%
\contentsline {section}{\numberline {10.4}Iliac Artery Aneurysms}{170}{section.10.4}%
\contentsline {subsection}{\numberline {10.4.1}Demographics}{170}{subsection.10.4.1}%
\contentsline {subsection}{\numberline {10.4.2}Presentation}{170}{subsection.10.4.2}%
\contentsline {subsection}{\numberline {10.4.3}Management}{170}{subsection.10.4.3}%
\contentsline {chapter}{\numberline {11}Mesenteric Disease}{172}{chapter.11}%
\contentsline {section}{\numberline {11.1}Acute Mesenteric Ischemia}{172}{section.11.1}%
\contentsline {subsection}{\numberline {11.1.1}Presentation and Evaluation}{172}{subsection.11.1.1}%
\contentsline {subsection}{\numberline {11.1.2}Management}{173}{subsection.11.1.2}%
\contentsline {subsection}{\numberline {11.1.3}Other Etiologies}{178}{subsection.11.1.3}%
\contentsline {section}{\numberline {11.2}Chronic Mesenteric Ischemia}{179}{section.11.2}%
\contentsline {subsection}{\numberline {11.2.1}Presentation and Evaluation}{179}{subsection.11.2.1}%
\contentsline {subsection}{\numberline {11.2.2}Management}{180}{subsection.11.2.2}%
\contentsline {section}{\numberline {11.3}Visceral Aneurysms}{181}{section.11.3}%
\contentsline {subsection}{\numberline {11.3.1}SMA Aneurysm}{182}{subsection.11.3.1}%
\contentsline {subsection}{\numberline {11.3.2}Splenic Aneurysm}{182}{subsection.11.3.2}%
\contentsline {section}{\numberline {11.4}Median Arcuate Ligament Syndrome (MALS)}{182}{section.11.4}%
\contentsline {section}{\numberline {11.5}SMA Syndrome}{183}{section.11.5}%
\contentsline {section}{\numberline {11.6}Uterine Fibroids}{183}{section.11.6}%
\contentsline {chapter}{\numberline {12}Renal}{184}{chapter.12}%
\contentsline {section}{\numberline {12.1}Renovascular Ischemic Disease}{184}{section.12.1}%
\contentsline {subsection}{\numberline {12.1.1}Pathophysiology}{184}{subsection.12.1.1}%
\contentsline {subsection}{\numberline {12.1.2}Evaluation}{187}{subsection.12.1.2}%
\contentsline {subsection}{\numberline {12.1.3}Management}{189}{subsection.12.1.3}%
\contentsline {subsubsection}{\numberline {12.1.3.1}Medical Management}{189}{subsubsection.12.1.3.1}%
\contentsline {subsubsection}{\numberline {12.1.3.2}Endovascular}{190}{subsubsection.12.1.3.2}%
\contentsline {paragraph}{\numberline {12.1.3.2.1}Outcomes}{193}{paragraph.12.1.3.2.1}%
\contentsline {paragraph}{\numberline {12.1.3.2.2}Complications}{194}{paragraph.12.1.3.2.2}%
\contentsline {paragraph}{\numberline {12.1.3.2.3}Surveillance}{195}{paragraph.12.1.3.2.3}%
\contentsline {subsubsection}{\numberline {12.1.3.3}Open Surgery}{195}{subsubsection.12.1.3.3}%
\contentsline {paragraph}{\numberline {12.1.3.3.1}Complications}{196}{paragraph.12.1.3.3.1}%
\contentsline {section}{\numberline {12.2}Fibromuscular Dysplasia (FMD)}{197}{section.12.2}%
\contentsline {subsection}{\numberline {12.2.1}Demographics}{197}{subsection.12.2.1}%
\contentsline {subsubsection}{\numberline {12.2.1.1}Etiology}{198}{subsubsection.12.2.1.1}%
\contentsline {subsubsection}{\numberline {12.2.1.2}Presentation}{199}{subsubsection.12.2.1.2}%
\contentsline {subsection}{\numberline {12.2.2}Evaluation}{201}{subsection.12.2.2}%
\contentsline {subsection}{\numberline {12.2.3}Management}{202}{subsection.12.2.3}%
\contentsline {subsubsection}{\numberline {12.2.3.1}Medical Management}{202}{subsubsection.12.2.3.1}%
\contentsline {subsubsection}{\numberline {12.2.3.2}Endovascular}{203}{subsubsection.12.2.3.2}%
\contentsline {subsubsection}{\numberline {12.2.3.3}Surgery}{207}{subsubsection.12.2.3.3}%
\contentsline {section}{\numberline {12.3}Renal Artery Aneurysms}{208}{section.12.3}%
\contentsline {subsection}{\numberline {12.3.1}Demographics}{208}{subsection.12.3.1}%
\contentsline {subsection}{\numberline {12.3.2}Anatomy}{208}{subsection.12.3.2}%
\contentsline {subsection}{\numberline {12.3.3}Presentation}{209}{subsection.12.3.3}%
\contentsline {subsection}{\numberline {12.3.4}Management}{209}{subsection.12.3.4}%
\contentsline {section}{\numberline {12.4}Renal Artery Dissection}{210}{section.12.4}%
\contentsline {subsection}{\numberline {12.4.1}Demographics}{210}{subsection.12.4.1}%
\contentsline {subsubsection}{\numberline {12.4.1.1}Presentation}{210}{subsubsection.12.4.1.1}%
\contentsline {subsection}{\numberline {12.4.2}Evaluation}{210}{subsection.12.4.2}%
\contentsline {subsection}{\numberline {12.4.3}Management}{210}{subsection.12.4.3}%
\contentsline {section}{\numberline {12.5}Nutcracker Syndrome}{210}{section.12.5}%
\contentsline {subsection}{\numberline {12.5.1}Demographics}{210}{subsection.12.5.1}%
\contentsline {subsubsection}{\numberline {12.5.1.1}Etiology}{210}{subsubsection.12.5.1.1}%
\contentsline {subsubsection}{\numberline {12.5.1.2}Presentation}{211}{subsubsection.12.5.1.2}%
\contentsline {subsection}{\numberline {12.5.2}Evaluation}{211}{subsection.12.5.2}%
\contentsline {subsection}{\numberline {12.5.3}Management}{211}{subsection.12.5.3}%
\contentsline {section}{\numberline {12.6}Renal Vein Thrombosis}{211}{section.12.6}%
\contentsline {subsection}{\numberline {12.6.1}Evaluation}{211}{subsection.12.6.1}%
\contentsline {subsection}{\numberline {12.6.2}Management}{211}{subsection.12.6.2}%
\contentsline {section}{\numberline {12.7}Renal Arteriovenous Fistula}{212}{section.12.7}%
\contentsline {subsection}{\numberline {12.7.1}Presentation}{212}{subsection.12.7.1}%
\contentsline {subsection}{\numberline {12.7.2}Evaluation}{212}{subsection.12.7.2}%
\contentsline {subsection}{\numberline {12.7.3}Management}{212}{subsection.12.7.3}%
\contentsline {chapter}{\numberline {13}Trauma - Arterial}{213}{chapter.13}%
\contentsline {section}{\numberline {13.1}General Principles}{213}{section.13.1}%
\contentsline {section}{\numberline {13.2}Basic Exposure Techniques}{214}{section.13.2}%
\contentsline {subsection}{\numberline {13.2.1}Supraceliac Control}{215}{subsection.13.2.1}%
\contentsline {subsection}{\numberline {13.2.2}Visceral Rotation}{217}{subsection.13.2.2}%
\contentsline {subsection}{\numberline {13.2.3}Exposure of Infrarenal Aorta}{218}{subsection.13.2.3}%
\contentsline {section}{\numberline {13.3}Management}{219}{section.13.3}%
\contentsline {subsection}{\numberline {13.3.1}Celiac Artery}{219}{subsection.13.3.1}%
\contentsline {subsection}{\numberline {13.3.2}Common Hepatic Artery (CHA)}{220}{subsection.13.3.2}%
\contentsline {subsection}{\numberline {13.3.3}Gastroduodenal Artery (GDA)}{221}{subsection.13.3.3}%
\contentsline {subsection}{\numberline {13.3.4}Splenic Artery}{221}{subsection.13.3.4}%
\contentsline {subsection}{\numberline {13.3.5}Superior Mesenteric Artery (SMA)}{221}{subsection.13.3.5}%
\contentsline {subsection}{\numberline {13.3.6}Inferior Mesenteric Artery (IMA)}{223}{subsection.13.3.6}%
\contentsline {subsection}{\numberline {13.3.7}Renal Arteries}{223}{subsection.13.3.7}%
\contentsline {chapter}{\numberline {14}Trauma - Venous}{225}{chapter.14}%
\contentsline {section}{\numberline {14.1}General Principles}{225}{section.14.1}%
\contentsline {subsection}{\numberline {14.1.1}Anatomy}{225}{subsection.14.1.1}%
\contentsline {subsection}{\numberline {14.1.2}Non-operative management}{225}{subsection.14.1.2}%
\contentsline {subsection}{\numberline {14.1.3}Hemorrhage Control}{226}{subsection.14.1.3}%
\contentsline {subsection}{\numberline {14.1.4}Primary repair}{226}{subsection.14.1.4}%
\contentsline {subsection}{\numberline {14.1.5}Ligation}{227}{subsection.14.1.5}%
\contentsline {section}{\numberline {14.2}Infrarenal IVC}{227}{section.14.2}%
\contentsline {subsection}{\numberline {14.2.1}Anatomy}{227}{subsection.14.2.1}%
\contentsline {subsection}{\numberline {14.2.2}Non-operative Management}{227}{subsection.14.2.2}%
\contentsline {subsection}{\numberline {14.2.3}Exposure}{227}{subsection.14.2.3}%
\contentsline {subsection}{\numberline {14.2.4}Hemorrhage Control}{227}{subsection.14.2.4}%
\contentsline {subsection}{\numberline {14.2.5}Primary Repair}{227}{subsection.14.2.5}%
\contentsline {subsection}{\numberline {14.2.6}Ligation}{228}{subsection.14.2.6}%
\contentsline {section}{\numberline {14.3}Renal/Suprarenal IVC}{228}{section.14.3}%
\contentsline {subsection}{\numberline {14.3.1}Anatomy}{228}{subsection.14.3.1}%
\contentsline {subsection}{\numberline {14.3.2}Non-operative Management}{228}{subsection.14.3.2}%
\contentsline {subsection}{\numberline {14.3.3}Exposure}{228}{subsection.14.3.3}%
\contentsline {subsection}{\numberline {14.3.4}Primary Repair}{229}{subsection.14.3.4}%
\contentsline {subsection}{\numberline {14.3.5}Ligation}{229}{subsection.14.3.5}%
\contentsline {section}{\numberline {14.4}Retrohepatic IVC}{229}{section.14.4}%
\contentsline {subsection}{\numberline {14.4.1}Anatomy}{229}{subsection.14.4.1}%
\contentsline {subsection}{\numberline {14.4.2}Management}{229}{subsection.14.4.2}%
\contentsline {subsection}{\numberline {14.4.3}Exposure}{229}{subsection.14.4.3}%
\contentsline {subsection}{\numberline {14.4.4}Hemorrhage Control}{229}{subsection.14.4.4}%
\contentsline {subsection}{\numberline {14.4.5}Primary Repair}{230}{subsection.14.4.5}%
\contentsline {subsection}{\numberline {14.4.6}Ligation}{230}{subsection.14.4.6}%
\contentsline {section}{\numberline {14.5}Suprahepatic IVC}{231}{section.14.5}%
\contentsline {subsection}{\numberline {14.5.1}Anatomy}{231}{subsection.14.5.1}%
\contentsline {subsection}{\numberline {14.5.2}Non-operative Management}{231}{subsection.14.5.2}%
\contentsline {subsection}{\numberline {14.5.3}Exposure}{231}{subsection.14.5.3}%
\contentsline {subsection}{\numberline {14.5.4}Hemorrhage Control}{231}{subsection.14.5.4}%
\contentsline {subsection}{\numberline {14.5.5}Primary Repair}{231}{subsection.14.5.5}%
\contentsline {subsection}{\numberline {14.5.6}Ligation}{231}{subsection.14.5.6}%
\contentsline {section}{\numberline {14.6}Portal Vein and Superior Mesenteric Vein Injuries}{231}{section.14.6}%
\contentsline {subsection}{\numberline {14.6.1}Exposure}{232}{subsection.14.6.1}%
\contentsline {subsection}{\numberline {14.6.2}Management}{232}{subsection.14.6.2}%
\contentsline {part}{\numberline {V}Lower Extremity}{233}{part.5}%
\contentsline {chapter}{\numberline {15}Medical Management and Claudication}{234}{chapter.15}%
\contentsline {section}{\numberline {15.1}Pathogenesis of peripheral arterial disease}{234}{section.15.1}%
\contentsline {subsection}{\numberline {15.1.1}Risk Factors}{235}{subsection.15.1.1}%
\contentsline {subsection}{\numberline {15.1.2}Landmark Studies}{239}{subsection.15.1.2}%
\contentsline {section}{\numberline {15.2}Intermittent Claudication}{239}{section.15.2}%
\contentsline {subsection}{\numberline {15.2.1}Evaluation}{240}{subsection.15.2.1}%
\contentsline {subsection}{\numberline {15.2.2}Management}{243}{subsection.15.2.2}%
\contentsline {subsubsection}{\numberline {15.2.2.1}Medical Management}{243}{subsubsection.15.2.2.1}%
\contentsline {subsubsection}{\numberline {15.2.2.2}Open and Endovascular Management}{246}{subsubsection.15.2.2.2}%
\contentsline {chapter}{\numberline {16}CLTI}{249}{chapter.16}%
\contentsline {section}{\numberline {16.1}Guidelines}{249}{section.16.1}%
\contentsline {section}{\numberline {16.2}Demographics}{250}{section.16.2}%
\contentsline {subsection}{\numberline {16.2.1}Etiology and Presentation}{250}{subsection.16.2.1}%
\contentsline {subsection}{\numberline {16.2.2}Natural History}{251}{subsection.16.2.2}%
\contentsline {subsection}{\numberline {16.2.3}WIFi Classification}{252}{subsection.16.2.3}%
\contentsline {subsection}{\numberline {16.2.4}Differential Diagnosis}{253}{subsection.16.2.4}%
\contentsline {section}{\numberline {16.3}Evaluation}{253}{section.16.3}%
\contentsline {subsection}{\numberline {16.3.1}Physiologic Testing}{254}{subsection.16.3.1}%
\contentsline {subsection}{\numberline {16.3.2}Imaging}{255}{subsection.16.3.2}%
\contentsline {section}{\numberline {16.4}Management}{257}{section.16.4}%
\contentsline {subsection}{\numberline {16.4.1}Medical Managment}{257}{subsection.16.4.1}%
\contentsline {subsection}{\numberline {16.4.2}Endovascular and Surgical Management}{257}{subsection.16.4.2}%
\contentsline {subsection}{\numberline {16.4.3}Complications}{262}{subsection.16.4.3}%
\contentsline {chapter}{\numberline {17}Acute Limb Ischemia}{263}{chapter.17}%
\contentsline {section}{\numberline {17.1}Overview}{263}{section.17.1}%
\contentsline {subsection}{\numberline {17.1.1}Demographics}{263}{subsection.17.1.1}%
\contentsline {subsubsection}{\numberline {17.1.1.1}Etiology}{263}{subsubsection.17.1.1.1}%
\contentsline {subsubsection}{\numberline {17.1.1.2}Presentation}{264}{subsubsection.17.1.1.2}%
\contentsline {subsection}{\numberline {17.1.2}Evaluation}{266}{subsection.17.1.2}%
\contentsline {subsection}{\numberline {17.1.3}Management}{266}{subsection.17.1.3}%
\contentsline {subsubsection}{\numberline {17.1.3.1}Medical Management}{267}{subsubsection.17.1.3.1}%
\contentsline {subsubsection}{\numberline {17.1.3.2}Surgical Management}{267}{subsubsection.17.1.3.2}%
\contentsline {subsubsection}{\numberline {17.1.3.3}Endovascular Management}{267}{subsubsection.17.1.3.3}%
\contentsline {subsubsection}{\numberline {17.1.3.4}Relevant Literature}{268}{subsubsection.17.1.3.4}%
\contentsline {subsubsection}{\numberline {17.1.3.5}Decision Making}{269}{subsubsection.17.1.3.5}%
\contentsline {section}{\numberline {17.2}Compartment Syndrome}{269}{section.17.2}%
\contentsline {subsection}{\numberline {17.2.1}Etiology}{269}{subsection.17.2.1}%
\contentsline {subsection}{\numberline {17.2.2}Evaluation}{270}{subsection.17.2.2}%
\contentsline {subsection}{\numberline {17.2.3}Management}{271}{subsection.17.2.3}%
\contentsline {section}{\numberline {17.3}Blue Toe Syndrome}{272}{section.17.3}%
\contentsline {subsection}{\numberline {17.3.1}Etiology and Presentation}{272}{subsection.17.3.1}%
\contentsline {subsection}{\numberline {17.3.2}Evaluation}{273}{subsection.17.3.2}%
\contentsline {subsection}{\numberline {17.3.3}Management}{273}{subsection.17.3.3}%
\contentsline {section}{\numberline {17.4}Non-atheromatous Popliteal Artery Disease}{273}{section.17.4}%
\contentsline {subsection}{\numberline {17.4.1}Popliteal Artery Entrapment Syndrome (PAES)}{273}{subsection.17.4.1}%
\contentsline {subsubsection}{\numberline {17.4.1.1}Etiology and Presentation}{273}{subsubsection.17.4.1.1}%
\contentsline {subsubsection}{\numberline {17.4.1.2}Evaluation}{274}{subsubsection.17.4.1.2}%
\contentsline {subsubsection}{\numberline {17.4.1.3}Management}{274}{subsubsection.17.4.1.3}%
\contentsline {subsection}{\numberline {17.4.2}Cystic Adventitial Disease}{274}{subsection.17.4.2}%
\contentsline {subsubsection}{\numberline {17.4.2.1}Etiology and Presentation}{274}{subsubsection.17.4.2.1}%
\contentsline {subsubsection}{\numberline {17.4.2.2}Evaluation}{274}{subsubsection.17.4.2.2}%
\contentsline {subsubsection}{\numberline {17.4.2.3}Management}{274}{subsubsection.17.4.2.3}%
\contentsline {section}{\numberline {17.5}Amputations}{275}{section.17.5}%
\contentsline {subsection}{\numberline {17.5.1}Above-knee, trans-femoral amputation (AKA)}{275}{subsection.17.5.1}%
\contentsline {subsection}{\numberline {17.5.2}Below-knee, trans-tibial amputation (BKA)}{275}{subsection.17.5.2}%
\contentsline {subsection}{\numberline {17.5.3}Transmetatarsal amputation (TMA)}{275}{subsection.17.5.3}%
\contentsline {chapter}{\numberline {18}Venous Disease}{276}{chapter.18}%
\contentsline {section}{\numberline {18.1}Chronic Venous Insufficiency}{276}{section.18.1}%
\contentsline {subsection}{\numberline {18.1.1}Terminology and Presentation}{276}{subsection.18.1.1}%
\contentsline {subsection}{\numberline {18.1.2}Evaluation}{278}{subsection.18.1.2}%
\contentsline {subsection}{\numberline {18.1.3}Management}{278}{subsection.18.1.3}%
\contentsline {subsubsection}{\numberline {18.1.3.1}Endovenous}{279}{subsubsection.18.1.3.1}%
\contentsline {subsubsection}{\numberline {18.1.3.2}Open Surgery}{283}{subsubsection.18.1.3.2}%
\contentsline {subsubsection}{\numberline {18.1.3.3}Medical Management}{284}{subsubsection.18.1.3.3}%
\contentsline {subsection}{\numberline {18.1.4}Other Complications of Superficial Venous Disease}{285}{subsection.18.1.4}%
\contentsline {subsubsection}{\numberline {18.1.4.1}Superficial Vein Thrombosis}{285}{subsubsection.18.1.4.1}%
\contentsline {subsubsection}{\numberline {18.1.4.2}Bleeding}{286}{subsubsection.18.1.4.2}%
\contentsline {section}{\numberline {18.2}Acute Deep Venous Thrombosis (DVT)}{286}{section.18.2}%
\contentsline {subsection}{\numberline {18.2.1}Demographics}{287}{subsection.18.2.1}%
\contentsline {subsubsection}{\numberline {18.2.1.1}Physiology}{287}{subsubsection.18.2.1.1}%
\contentsline {subsubsection}{\numberline {18.2.1.2}Prevalence}{287}{subsubsection.18.2.1.2}%
\contentsline {subsubsection}{\numberline {18.2.1.3}Etiology}{287}{subsubsection.18.2.1.3}%
\contentsline {subsection}{\numberline {18.2.2}Evaluation}{289}{subsection.18.2.2}%
\contentsline {subsection}{\numberline {18.2.3}Management}{290}{subsection.18.2.3}%
\contentsline {subsubsection}{\numberline {18.2.3.1}Medical}{290}{subsubsection.18.2.3.1}%
\contentsline {paragraph}{\numberline {18.2.3.1.1}Complications - Pulmonary Embolism}{292}{paragraph.18.2.3.1.1}%
\contentsline {paragraph}{\numberline {18.2.3.1.2}Complications - Post Thrombotic Syndrome}{293}{paragraph.18.2.3.1.2}%
\contentsline {paragraph}{\numberline {18.2.3.1.3}Complications - IVC Filters}{293}{paragraph.18.2.3.1.3}%
\contentsline {subsubsection}{\numberline {18.2.3.2}Surgery}{294}{subsubsection.18.2.3.2}%
\contentsline {subsubsection}{\numberline {18.2.3.3}Endovascular}{295}{subsubsection.18.2.3.3}%
\contentsline {section}{\numberline {18.3}Phlegmasia}{296}{section.18.3}%
\contentsline {section}{\numberline {18.4}Deep Venous Obstruction}{297}{section.18.4}%
\contentsline {subsection}{\numberline {18.4.1}Etiology}{297}{subsection.18.4.1}%
\contentsline {subsection}{\numberline {18.4.2}Evaluation}{298}{subsection.18.4.2}%
\contentsline {subsection}{\numberline {18.4.3}Management}{301}{subsection.18.4.3}%
\contentsline {subsubsection}{\numberline {18.4.3.1}Endovascular}{301}{subsubsection.18.4.3.1}%
\contentsline {subsubsection}{\numberline {18.4.3.2}Surgery}{302}{subsubsection.18.4.3.2}%
\contentsline {section}{\numberline {18.5}Pelvic Congestive Syndrome}{303}{section.18.5}%
\contentsline {subsection}{\numberline {18.5.1}Presentation}{303}{subsection.18.5.1}%
\contentsline {subsection}{\numberline {18.5.2}Evaluation and Management}{303}{subsection.18.5.2}%
\contentsline {section}{\numberline {18.6}Superior Vena Cava (SVC) Syndrome}{304}{section.18.6}%
\contentsline {subsection}{\numberline {18.6.1}Management}{304}{subsection.18.6.1}%
\contentsline {section}{\numberline {18.7}Lymphedema}{304}{section.18.7}%
\contentsline {subsection}{\numberline {18.7.1}Demographics}{305}{subsection.18.7.1}%
\contentsline {subsubsection}{\numberline {18.7.1.1}Etiology}{305}{subsubsection.18.7.1.1}%
\contentsline {subsubsection}{\numberline {18.7.1.2}Presentation}{305}{subsubsection.18.7.1.2}%
\contentsline {subsection}{\numberline {18.7.2}Evaluation}{305}{subsection.18.7.2}%
\contentsline {subsection}{\numberline {18.7.3}Management}{305}{subsection.18.7.3}%
\contentsline {chapter}{\numberline {19}Trauma - Peripheral}{307}{chapter.19}%
\contentsline {section}{\numberline {19.1}Demographics}{308}{section.19.1}%
\contentsline {subsection}{\numberline {19.1.1}Epidemiology}{308}{subsection.19.1.1}%
\contentsline {subsection}{\numberline {19.1.2}Types of Injuries}{308}{subsection.19.1.2}%
\contentsline {subsection}{\numberline {19.1.3}Presentation}{308}{subsection.19.1.3}%
\contentsline {section}{\numberline {19.2}Evaluation}{310}{section.19.2}%
\contentsline {section}{\numberline {19.3}Management}{311}{section.19.3}%
\contentsline {subsection}{\numberline {19.3.1}General Considerations}{311}{subsection.19.3.1}%
\contentsline {subsection}{\numberline {19.3.2}Iliac Vessels}{315}{subsection.19.3.2}%
\contentsline {subsection}{\numberline {19.3.3}Femoral Vessels}{316}{subsection.19.3.3}%
\contentsline {subsection}{\numberline {19.3.4}Popliteal Artery}{317}{subsection.19.3.4}%
\contentsline {subsection}{\numberline {19.3.5}Tibial Vessels}{318}{subsection.19.3.5}%
\contentsline {subsection}{\numberline {19.3.6}Subclavian and Proximal Axillary Arteries}{319}{subsection.19.3.6}%
\contentsline {subsection}{\numberline {19.3.7}Distal Axillary and Brachial Arteries}{320}{subsection.19.3.7}%
\contentsline {subsection}{\numberline {19.3.8}Radial and Ulnar Artery}{320}{subsection.19.3.8}%
\contentsline {section}{\numberline {19.4}Venous Injury}{321}{section.19.4}%
\contentsline {subsection}{\numberline {19.4.1}Lower Extremity Venous Injury}{321}{subsection.19.4.1}%
\contentsline {subsection}{\numberline {19.4.2}Upper Extremity Venous Injury}{321}{subsection.19.4.2}%
\contentsline {part}{\numberline {VI}General}{322}{part.6}%
\contentsline {chapter}{\numberline {20}Vascular Lab}{323}{chapter.20}%
\contentsline {section}{\numberline {20.1}\textbf {Overview}}{323}{section.20.1}%
\contentsline {subsection}{\numberline {20.1.1}Waveforms}{324}{subsection.20.1.1}%
\contentsline {section}{\numberline {20.2}Extracranial}{328}{section.20.2}%
\contentsline {section}{\numberline {20.3}Intracranial}{332}{section.20.3}%
\contentsline {section}{\numberline {20.4}Upper Extremity}{334}{section.20.4}%
\contentsline {subsection}{\numberline {20.4.1}Hemodialysis Access}{335}{subsection.20.4.1}%
\contentsline {section}{\numberline {20.5}Lower Extremity}{337}{section.20.5}%
\contentsline {subsection}{\numberline {20.5.1}Pathologies}{339}{subsection.20.5.1}%
\contentsline {subsubsection}{\numberline {20.5.1.1}Pseudoaneurysms (particularly femoral)}{340}{subsubsection.20.5.1.1}%
\contentsline {subsubsection}{\numberline {20.5.1.2}Dissections}{340}{subsubsection.20.5.1.2}%
\contentsline {subsubsection}{\numberline {20.5.1.3}Buerger's Disease}{341}{subsubsection.20.5.1.3}%
\contentsline {subsubsection}{\numberline {20.5.1.4}Cystic Adventitial Disease}{341}{subsubsection.20.5.1.4}%
\contentsline {subsubsection}{\numberline {20.5.1.5}Bakers Cyst}{342}{subsubsection.20.5.1.5}%
\contentsline {section}{\numberline {20.6}Abdominal}{342}{section.20.6}%
\contentsline {subsection}{\numberline {20.6.1}Aorta}{342}{subsection.20.6.1}%
\contentsline {subsection}{\numberline {20.6.2}Mesenteric Vasculature}{344}{subsection.20.6.2}%
\contentsline {subsection}{\numberline {20.6.3}Portal Vein}{345}{subsection.20.6.3}%
\contentsline {subsection}{\numberline {20.6.4}Renal arteries}{346}{subsection.20.6.4}%
\contentsline {section}{\numberline {20.7}Venous}{346}{section.20.7}%
\contentsline {subsection}{\numberline {20.7.1}Reflux}{348}{subsection.20.7.1}%
\contentsline {subsection}{\numberline {20.7.2}May Thurner Syndrome}{350}{subsection.20.7.2}%
\contentsline {subsection}{\numberline {20.7.3}Nutcracker Syndrome}{350}{subsection.20.7.3}%
\contentsline {subsection}{\numberline {20.7.4}\textbf {Thrombosis}}{350}{subsection.20.7.4}%
\contentsline {subsection}{\numberline {20.7.5}Vein Mapping}{352}{subsection.20.7.5}%
\contentsline {section}{\numberline {20.8}Artifacts}{353}{section.20.8}%
\contentsline {section}{\numberline {20.9}Accreditation and Credentialing}{355}{section.20.9}%
\contentsline {chapter}{\numberline {21}Radiation Safety}{358}{chapter.21}%
\contentsline {section}{\numberline {21.1}Important Terms}{358}{section.21.1}%
\contentsline {section}{\numberline {21.2}Radiation effects}{359}{section.21.2}%
\contentsline {section}{\numberline {21.3}Risk factors}{359}{section.21.3}%
\contentsline {section}{\numberline {21.4}Reduction strategies}{360}{section.21.4}%
\contentsline {subsection}{\numberline {21.4.1}Pregnancy considerations}{361}{subsection.21.4.1}%
\contentsline {subsection}{\numberline {21.4.2}Regulation}{362}{subsection.21.4.2}%
\contentsline {section}{\numberline {21.5}Contrast Reduction}{363}{section.21.5}%
\contentsline {subsection}{\numberline {21.5.1}CO2 Angiography}{363}{subsection.21.5.1}%
\contentsline {subsubsection}{\numberline {21.5.1.1}Limitations}{364}{subsubsection.21.5.1.1}%
\contentsline {subsubsection}{\numberline {21.5.1.2}Complications}{364}{subsubsection.21.5.1.2}%
\contentsline {chapter}{\numberline {22}Endovascular Access}{365}{chapter.22}%
\contentsline {section}{\numberline {22.1}Complications}{370}{section.22.1}%
\contentsline {chapter}{\numberline {23}Rapid Review}{372}{chapter.23}%
\contentsline {section}{\numberline {23.1}Venous Disease}{372}{section.23.1}%
\contentsline {section}{\numberline {23.2}Vascular Lab}{373}{section.23.2}%
\contentsline {subsection}{\numberline {23.2.1}TCD}{373}{subsection.23.2.1}%
\contentsline {subsection}{\numberline {23.2.2}Basics}{374}{subsection.23.2.2}%
\contentsline {subsection}{\numberline {23.2.3}Sizes and Velocities}{374}{subsection.23.2.3}%
\contentsline {section}{\numberline {23.3}Zebras}{376}{section.23.3}%
\contentsline {chapter}{References}{379}{chapter*.40}%
\providecommand \tocbasic@end@toc@file {}\tocbasic@end@toc@file 
